Composition and therapeutic utility of conotoxins from genus Conus. Patent status 1996 - 2000

Expert Opinion on Therapeutic Patents

Volumn 11, Issue 4, 2001, Pages 603-623

  Jones, R M ^a   Cartier, G E ^a   McIntosh, J M ^a   Bulaj, G ^a   Farrar, V E ^a   Olivera, B M ^a  

^a Cognetix Inc ^*  (United States)

Author keywords

Conantokin G; Conopeptide; Conotoxin; Conus; Epilepsy; Ion channel; Nicotinic acetylcholine receptor (nAChR); NMDA channel; Pain; Phage display; Ziconotide

Indexed keywords

ACETYLCHOLINE; ALPHA A CONOTOXIN; ALPHA CONOTOXIN; BROMOSLEEPER CONOTOXIN; CALCIUM CHANNEL; CGX 1160; CHI CONOTOXIN; COMPLEMENTARY DNA; CONANTOKIN; CONANTOKIN G; CONOTOXIN; CONTRYPHAN; CONTULAKIN; CYSTEINE; DELTA CONOTOXIN; DISULFIDE; GAMMA CONOTOXIN; KAPPA A CONOTOXIN; MU CONOTOXIN; MU O CONOTOXIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROTENSIN RECEPTOR; NEUROTRANSMITTER; NICOTINE; NICOTINIC RECEPTOR; OMEGA CONOTOXIN; OMEGA CONOTOXIN MVIIA; POTASSIUM CHANNEL; PSI CONOTOXIN; RHO CONOTOXIN; SIGMA CONOTOXIN; SODIUM CHANNEL; TAU CONOTOXIN; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AFFECTIVE NEUROSIS; ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BLOOD PRESSURE REGULATION; BOTULISM; CANCER LOCALIZATION; CARDIOVASCULAR DISEASE; CELL PROLIFERATION; CHANNEL GATING; COGNITIVE DEFECT; CONOTOXIN GS; DRUG POTENTIATION; EATON LAMBERT SYNDROME; ENCEPHALOMYELITIS; EPILEPSY; FARMER LUNG; GASTROPOD; HEART ARRHYTHMIA; HUMAN; HUNTINGTON CHOREA; HYPERGLYCEMIA; INFLAMMATION; INTRACTABLE PAIN; LUNG SMALL CELL CANCER; MALIGNANT NEOPLASTIC DISEASE; METACHROMATIC LEUKODYSTROPHY; MULTIPLE SCLEROSIS; MUSCLE RELAXATION; MYASTHENIA GRAVIS; NEUROLOGIC DISEASE; NONHUMAN; OPTIC NERVE DISEASE; PATENT; PELIZAEUS MERZBACHER DISEASE; PSYCHOSIS; RAT; REVIEW; SCHIZOPHRENIA; SMOKING CESSATION; SNAIL; SPINAL CORD INJURY; STOMACH MOTILITY; URINE INCONTINENCE;

EID: 0035065039     PISSN: 13543776     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543776.11.4.603     Document Type: Review

References (51)

1. Combinatorial chemistry at a cone snails pace
2. Conotoxins - New vistas for peptide therapeutics
3. The spasmodic peptide defines a new conotoxin superfamily
4. Ziconotide, Neurex Corp
5. An Evaluation of intrathecal ziconotide for treatment of chronic pain
6. Structures of the contryphan family of cyclic peptides. Role of electrostatic interactions in cis-trans isomerism
7. Functional expression of a new pharmacological subtype of brain nicotinic acetylcholine receptor
8. Isolation of a cDNA clone coding for a possible neural nicotinic acetylcholine receptor α-subunit
9. Members of a nicotinic acetylcholine receptor gene family are expressed in different regions of the mammalian central nervous system
10. Primary structure and expression of β2: A novel subunit of neuronal nicotinic acetylcholine receptors
11. The functional diversity of the neuronal nicotinic acetylcholine receptors is increased by a novel subunit: β4
12. α9: An acetylcholine receptor with novel pharmacological properties expressed in rat cochlear hair cells
13. Neurons can maintain multiple classes of nicotinic acetylcholine receptors distinguished by different subunit compositions
14. Presynaptic nicotinic ACh receptors
15. Serotonin release and cell proliferation are under the control of α-bungarotoxin-sensitive nicotinic receptors in small-cell lung carcinoma cell lines
16. 3H]-dopamine release
17. Stereoselective nicotine-induced release of dopamine from striatal synaptosomes: Concentration dependence and repetitive stimulation
18. 3H]acetylcholine release from mouse cerebral cortical synaptosomes
19. Hippocampal nicotinic autoreceptors modulate acetylcholine release
20. Differential block of nicotinic synapses on B versus C neurones in sympathetic ganglia of frog by α-conotoxins MII and ImI
21. 2+ influx
22. Isolation and characterization of a novel conus peptide with apparent antinociceptive activity
23. Ι-conotoxins, a new family of conotoxins with unique disulfide pattern and protein folding: Isolation and characterization from the venom of Conus marmoreus
24. Strategy for rapid immobilization of prey by a fish-hunting cone snail
25. γ-Conotoxin-PnVIIA, a γ-carboxyglutamate-containing peptide agonist of neuronal pacemaker cation currents
26. Inactivation of a serotonin-gated ion channel by a polypeptide toxin from marine snails
27. ω-Conotoxin MVIIA: From marine snail venom to analgesic drug
28. μ-Conotoxin PIIIA, a new peptide for discriminating among tetrodotoxin-sensitive Na channel subtypes
29. Purification, characterization, synthesis, and cloning of the lockjaw peptide from Conus purpurascens venom
30. μ-conotoxin GIIIA, a peptide ligand for muscle sodium channels: Chemical synthesis, radiolabeling, and receptor characterization
31. Distinction among neuronal subtypes of voltage-activated sodium channels by μ-conotoxin PIIIA
32. Contulakin-G, an O-glycosylated invertebrate neurotensin
33. Excitatory amino acid receptors in the vertebrate central nervous system
34. Excitatory amino acid receptors: A gallery of new targets for pharmacological interyention
35. (3SR, 4aRS, 6RS, 8aRS)-6-[2-(1H-tetrazol-5-yl) ethyl]decahydroisoquinoline-3-carboxylic acid: A structurally novel, systemically active, competitive AMPA receptor
36. In vitro and in vivo antagonism of AMPA receptor activation by (3S, 4aR, 6R, 8aR)-6-[2-(1(2)H-tetrazole-5-yl) ethyl] decahydroisoquinoline -3-carboxylic acid
37. 6-substituted decahydroisoquinoline-3-carboxylic acids as potent and selective conformationally constrained NMDA receptor antagonists
38. 4-(Tetrazolylalkyl)piperidine-2-carboxylic acids. Potent and selective N-methyl-D-aspartic acid receptor antagonists with a short duration of action
39. NMDA antagonist activity of (+/-)-(2SR,4RS)-4-(1H-tetrazol-5-ylmethyl) piperidine-2-carboxylic acid resides with the (-)-2R,4S-isomer
40. (3SR,4aRS,6aRS,8aRS)-6 -(1H-tetrazol-5-yl) decahydroisoquinoline-3 -carboxylic acid, a novel, competitive, systemically active NMDA and AMPA receptor antagonist
41. Structure-activity studies of 6-substituted decahydroisoquinoline-3-carboxylic acid AMPA receptor antagonists. 2. Effects of distal acid bioisosteric substitution, absolute stereochemical preferences, and in vivo activity
42. Structure-activity studies of 6-(tetrazolylalkyl)-substituted decahydroisoquinoline-3-carboxylic acid AMPA receptor antagonists. 1. Effects of stereochemistry, chain length, and chain substitution
43. Conantokin-T. A γ-carboxyglutamate containing peptide with N-methyl-D-aspartate antagonist activity
44. Noncompetitive inhibition of N-methyl-D-aspartate by conantokin-G: Evidence for an allosteric interaction at polyamine sites
45. Conantokin-T selectively antagonizes N-methyl-D-aspartate-evoked responses in rat hippocampal slice
46. Conantokin-G selectively inhibits N-methyl-D-aspartate-induced currents in Xenopus oocytes injected with mouse brain mRNA
47. Synthetic analogues of conantokin-G: NMDA antagonists acting through a novel polyamine-coupled site
48. Introduction of unnatural amino acids into proteins using expressed protein ligation
49. Fmoc-based synthesis of peptide-thioesters:application to the total chemical synthesis of a glycoprotein by native chemical ligation
50. Delivery of peptide therapeutics